Transistion from manual to femto keratoplasty

Article

A commitment to predictability and safety

The introduction of femtosecond laser technology in the ophthalmologic practice has given rise to significant advances in a great variety of corneal surgical procedures, especially in terms of predictability and safety. This technology, based on the use of a solid state laser (Nd:Glass) beam of a wavelength of 1040–1060 nm, is able to induce a photodisruption of the corneal tissue at a specific plane without thermal or shockwave damage to the surrounding tissue, and with a extremely high level of precision. Specifically, femtosecond lasers form a series of microbubbles (3–12 µm) of carbon dioxide and water vapour due to the photodisruption induced at the programmed depth. These microbubbles interconnect generating a dissection plane. This capability of femtosecond laser technology of precisely programming and generating different types of corneal tissue dissections makes it a valuable tool for keratoplasty.

A valuable tool

Another significant advantage of femto keratoplasty is the possibility of customizing the corneal trephination according to an established pattern. As presented at Femto Keratoplasty Forum 2012 by Dr Thomas Neuhann, it is highly recommended to use dissections with an internal diameter smaller than the external and slanted inwards to promote good self healing.7 This can easily be achieved with the zigzag, tongue in groove ('barrel'), and 'square-zag' shapes.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
Related Content
© 2024 MJH Life Sciences

All rights reserved.